Research Topics
| Millie D LongSummaryAffiliation: University of North Carolina Country: USA Publications
| Collaborators
|
Detail Information
Publications
Increased risk of pneumonia among patients with inflammatory bowel diseaseMillie D Long
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
Am J Gastroenterol 108:240-8. 2013..Patients with inflammatory bowel disease (IBD) may be at increased risk for infections. We aimed to determine the pneumonia risk in IBD and how specific medications affect this risk...- Increased risk of herpes zoster among 108 604 patients with inflammatory bowel diseaseM D Long
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7080, USA
Aliment Pharmacol Ther 37:420-9. 2013..Patients with inflammatory bowel disease (IBD) on certain immunosuppressants have increased herpes zoster (HZ) risk... - Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel diseaseMillie D Long
Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
Gastroenterology 143:390-399.e1. 2012..Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin cancer (NMSC) in patients with IBD and how medications affect these risks... - Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial resultsMillie D Long
University of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599, USA
Inflamm Bowel Dis 18:2099-106. 2012..The widespread use of the Internet allows for unique research opportunities. We aimed to develop and follow an Internet-based cohort (e-cohort) of patients with self-reported inflammatory bowel diseases (IBD) over time... - Narcotic use for inflammatory bowel disease and risk factors during hospitalizationMillie D Long
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
Inflamm Bowel Dis 18:869-76. 2012..We sought to study the relationship between narcotic use, objective measures of disease activity, and other associated factors in hospitalized patients with IBD... - Colorectal cancer testing in the national Veterans Health AdministrationMillie D Long
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Campus Box 7080, Chapel Hill, NC 27599 7080, USA
Dig Dis Sci 57:288-93. 2012..Colorectal cancer (CRC) screening is a priority for the Veteran's Health Administration (VHA). Optimizing fecal occult blood testing (FOBT) is integral to CRC screening in health care systems... 
Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel diseaseMillie D Long
University of North Carolina at Chapel Hill, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
Inflamm Bowel Dis 17:2162-8. 2011....- Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experienceMillie D Long
University of North Carolina at Chapel Hill, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
Inflamm Bowel Dis 17:1855-62. 2011..Capsule endoscopy (CE) is performed to assess inflammatory bowel disease (IBD). We aimed to define the results of CE in subtypes of IBD and to determine whether CE results in management changes... - Reduced polyp detection as endoscopy shift progresses: experience with screening colonoscopy at a tertiary-care hospitalMillie D Long
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599 7080, USA
J Clin Gastroenterol 45:253-8. 2011..To determine whether polyp detection rates are reduced as time progresses through half and full-day endoscopy shifts... - Nonmelanoma skin cancer in inflammatory bowel disease: a reviewMillie D Long
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, North Carolina 27599 7080, USA
Inflamm Bowel Dis 17:1423-7. 2011..We also offer recommendations for prevention of NMSC in these populations... - Hormone replacement therapy, oral contraceptive use, and distal large bowel cancer: a population-based case-control studyMillie D Long
Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
Am J Gastroenterol 105:1843-50. 2010..We aimed to determine the associations between hormone replacement therapy, oral contraceptive use, and distal large bowel cancer... - Bone health in a tertiary-care gastroenterology and hepatology populationMillie D Long
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599 7080, USA
Dig Dis Sci 55:2263-9. 2010..Glucocorticoid use is a major risk factor for osteoporosis. Overall rates of glucocorticoid use and bone health preventive measures in gastroenterology and hepatology populations are unknown... - Increased risk for non-melanoma skin cancer in patients with inflammatory bowel diseaseMillie D Long
Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina 27599 7080, USA
Clin Gastroenterol Hepatol 8:268-74. 2010..We evaluated the risk of non-melanoma skin cancer (NMSC) in patients with IBD and determined how immunosuppressive and biologic medications affect this risk... - Inverse relationship between moderate alcohol intake and rectal cancer: analysis of the North Carolina Colon Cancer StudySeth D Crockett
Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, North Carolina, USA
Dis Colon Rectum 54:887-94. 2011..The relationship between alcohol intake and rectal cancer is uncertain... - The association between diabetes, insulin use, and colorectal cancer among Whites and African AmericansLisa C Vinikoor
University of North Carolina, Chapel Hill, NC 27599 7555, USA
Cancer Epidemiol Biomarkers Prev 18:1239-42. 2009..No association was present among African Americans. Insulin use was also positively associated with rectal cancer among Whites... - Suboptimal rates of cervical testing among women with inflammatory bowel diseaseMillie D Long
Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
Clin Gastroenterol Hepatol 7:549-53. 2009..We aimed to determine cervical testing rates among women with IBD, specifically those on immunosuppressant medications, and to identify risk factors associated with low incidence of screening... - Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel diseaseMillie D Long
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina Center for Gastrointestinal Biology and Disease, Chapel Hill, North Carolina Section of Gastroenterology, Boston Medical Center, Boston University School of Medicine, Boston, Massachusetts Division of Gastroenterology and Hepatology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina
Inflamm Bowel Dis 19:1018-24. 2013..Our aims were (1) to determine the incidence and relative risk of PCP in IBD and (2) to describe medication exposures in patients with IBD with PCP... - Changing shape of disease: nonalcoholic fatty liver disease in Crohn's disease-a case series and review of the literatureChristopher E McGowan
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, 27599 7080, USA
Inflamm Bowel Dis 18:49-54. 2012..These changes may herald an increase in the incidence of nonalcoholic fatty liver disease (NAFLD) in this population... - Capsule and balloon endoscopy: When are they really needed in patients with inflammatory bowel diseases?Hans H Herfarth
Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA
Dig Dis 28:439-44. 2010..This review summarizes the current clinical status of capsule and balloon enteroscopy in patients with suspected or established IBD... - Evaluation of a non-invasive method to detect cytomegalovirus (CMV)-DNA in stool samples of patients with inflammatory bowel disease (IBD): a pilot studyHans H Herfarth
Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina, Bioinformatics Bldg, CB 7080, Chapel Hill, NC, 27599, USA
Dig Dis Sci 55:1053-8. 2010..The aim of this pilot study was to investigate the diagnostic efficacy of quantitative polymerase chain reaction (PCR) to detect CMV DNA in stool samples of IBD patients... - Methotrexate: underused and ignored?Hans H Herfarth
Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, NC 27599, USA hherf med unc edu
Dig Dis 30:112-8. 2012..This review investigates the potential reasons for the underuse of methotrexate in patients with inflammatory bowel diseases...